Met Life Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 134,727 shares of HALO stock, worth $6.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
134,727
Previous 136,825 1.53%
Holding current value
$6.4 Million
Previous $7.16 Million 7.58%
% of portfolio
0.05%
Previous 0.04%

Shares

68 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$51.3 - $64.42 $107,627 - $135,153
-2,098 Reduced 1.53%
134,727 $7.71 Million
Q2 2024

Aug 13, 2024
SELL
$37.81 - $52.4 $6,011 - $8,331
-159 Reduced 0.12%
136,825 $7.16 Million
Q1 2024

May 14, 2024
BUY
$33.68 - $41.95 $4.61 Million - $5.75 Million
136,984 New
136,984 $5.57 Million
Q4 2023

Feb 14, 2024
SELL
$33.32 - $42.1 $35,685 - $45,089
-1,071 Reduced 0.76%
140,117 $5.18 Million
Q3 2023

May 09, 2024
SELL
$36.46 - $44.03 $316,618 - $382,356
-8,684 Reduced 5.79%
141,188 $5.39 Million
Q3 2023

Apr 29, 2024
SELL
$36.46 - $44.03 $204,285 - $246,700
-5,603 Reduced 3.82%
141,188 $5.39 Million
Q3 2023

Nov 14, 2023
SELL
$36.46 - $44.03 $204,285 - $246,700
-5,603 Reduced 3.82%
141,188 $5.39 Million
Q2 2023

Apr 29, 2024
BUY
$30.28 - $38.74 $4.44 Million - $5.69 Million
146,791 New
146,791 $5.29 Million
Q2 2023

Aug 10, 2023
SELL
$30.28 - $38.74 $93,292 - $119,357
-3,081 Reduced 2.06%
146,791 $5.29 Million
Q1 2023

May 09, 2024
BUY
$32.86 - $55.7 $4.92 Million - $8.35 Million
149,872 New
149,872 $5.72 Billion
Q1 2023

May 15, 2023
SELL
$32.86 - $55.7 $73,113 - $123,932
-2,225 Reduced 1.46%
149,872 $5.72 Million
Q4 2022

May 10, 2024
SELL
$40.06 - $59.44 $227,941 - $338,213
-5,690 Reduced 3.61%
152,097 $8.65 Million
Q4 2022

Jun 14, 2023
BUY
$40.06 - $59.44 $89,133 - $132,254
2,225 Added 1.48%
152,097 $8.65 Million
Q4 2022

Mar 22, 2023
SELL
$40.06 - $59.44 $227,941 - $338,213
-5,690 Reduced 3.61%
152,097 $8.65 Million
Q4 2022

Feb 15, 2023
SELL
$40.06 - $59.44 $227,941 - $338,213
-5,690 Reduced 3.61%
152,097 $8.65 Million
Q3 2022

May 10, 2024
BUY
$38.53 - $51.78 $19,920 - $26,770
517 Added 0.33%
157,787 $6.24 Million
Q3 2022

Jun 14, 2023
BUY
$38.53 - $51.78 $304,964 - $409,838
7,915 Added 5.28%
157,787 $6.24 Million
Q3 2022

Mar 22, 2023
BUY
$38.53 - $51.78 $19,920 - $26,770
517 Added 0.33%
157,787 $6.24 Million
Q3 2022

Nov 14, 2022
BUY
$38.53 - $51.78 $19,920 - $26,770
517 Added 0.33%
157,787 $6.24 Million
Q2 2022

May 10, 2024
SELL
$37.35 - $48.3 $192,128 - $248,455
-5,144 Reduced 3.17%
157,270 $6.92 Million
Q2 2022

Jun 20, 2023
BUY
$37.35 - $48.3 $276,315 - $357,323
7,398 Added 4.94%
157,270 $6.92 Million
Q2 2022

Mar 22, 2023
SELL
$37.35 - $48.3 $192,128 - $248,455
-5,144 Reduced 3.17%
157,270 $6.92 Million
Q2 2022

Aug 11, 2022
SELL
$37.35 - $48.3 $192,128 - $248,455
-5,144 Reduced 3.17%
157,270 $6.92 Million
Q1 2022

May 10, 2024
BUY
$31.97 - $41.06 $5.19 Million - $6.67 Million
162,414 New
162,414 $6.48 Million
Q1 2022

Jun 20, 2023
BUY
$31.97 - $41.06 $400,967 - $514,974
12,542 Added 8.37%
162,414 $6.48 Million
Q1 2022

Mar 22, 2023
BUY
$31.97 - $41.06 $1.49 Million - $1.91 Million
46,458 Added 40.07%
162,414 $6.48 Million
Q1 2022

May 12, 2022
BUY
$31.97 - $41.06 $1.49 Million - $1.91 Million
46,458 Added 40.07%
162,414 $6.48 Million
Q4 2021

May 17, 2024
SELL
$31.82 - $40.75 $82,891 - $106,153
-2,605 Reduced 2.2%
115,956 $4.66 Million
Q4 2021

Jun 21, 2023
SELL
$31.82 - $40.75 $1.08 Million - $1.38 Million
-33,916 Reduced 22.63%
115,956 $4.66 Million
Q4 2021

Mar 22, 2023
SELL
$31.82 - $40.75 $82,891 - $106,153
-2,605 Reduced 2.2%
115,956 $4.66 Million
Q4 2021

Feb 15, 2022
SELL
$31.82 - $40.75 $82,891 - $106,153
-2,605 Reduced 2.2%
115,956 $4.66 Million
Q3 2021

May 17, 2024
BUY
$38.47 - $46.42 $57,743 - $69,676
1,501 Added 1.28%
118,561 $4.82 Million
Q3 2021

Jun 21, 2023
SELL
$38.47 - $46.42 $1.2 Million - $1.45 Million
-31,311 Reduced 20.89%
118,561 $4.82 Million
Q3 2021

Mar 22, 2023
BUY
$38.47 - $46.42 $57,743 - $69,676
1,501 Added 1.28%
118,561 $4.82 Million
Q3 2021

Nov 15, 2021
BUY
$38.47 - $46.42 $57,743 - $69,676
1,501 Added 1.28%
118,561 $4.82 Million
Q2 2021

May 17, 2024
BUY
$38.84 - $51.31 $46,413 - $61,315
1,195 Added 1.03%
117,060 $5.32 Million
Q2 2021

Jun 21, 2023
SELL
$38.84 - $51.31 $1.27 Million - $1.68 Million
-32,812 Reduced 21.89%
117,060 $5.32 Million
Q2 2021

Mar 22, 2023
BUY
$38.84 - $51.31 $46,413 - $61,315
1,195 Added 1.03%
117,060 $5.32 Million
Q2 2021

Aug 16, 2021
BUY
$38.84 - $51.31 $46,413 - $61,315
1,195 Added 1.03%
117,060 $5.32 Million
Q1 2021

May 17, 2024
SELL
$39.51 - $51.45 $834,411 - $1.09 Million
-21,119 Reduced 15.42%
115,865 $4.83 Million
Q1 2021

Jun 26, 2023
SELL
$39.51 - $51.45 $1.34 Million - $1.75 Million
-34,007 Reduced 22.69%
115,865 $4.83 Billion
Q1 2021

Mar 22, 2023
SELL
$39.51 - $51.45 $268,786 - $350,014
-6,803 Reduced 5.55%
115,865 $4.83 Million
Q1 2021

May 14, 2021
SELL
$39.51 - $51.45 $268,786 - $350,014
-6,803 Reduced 5.55%
115,865 $4.83 Million
Q4 2020

May 24, 2024
BUY
$25.81 - $43.62 $1.62 Million - $2.74 Million
62,759 Added 104.76%
122,668 $5.24 Million
Q4 2020

Jun 22, 2023
SELL
$25.81 - $43.62 $702,135 - $1.19 Million
-27,204 Reduced 18.15%
122,668 $5.24 Million
Q4 2020

Mar 22, 2023
BUY
$25.81 - $43.62 $1.62 Million - $2.74 Million
62,759 Added 104.76%
122,668 $5.24 Million
Q4 2020

Feb 16, 2021
BUY
$25.81 - $43.62 $1.62 Million - $2.74 Million
62,759 Added 104.76%
122,668 $5.24 Million
Q3 2020

Jun 26, 2023
SELL
$25.74 - $29.63 $2.32 Million - $2.67 Million
-89,963 Reduced 60.03%
59,909 $1.57 Million
Q2 2020

May 24, 2024
SELL
$16.25 - $26.81 $1.25 Million - $2.07 Million
-77,075 Reduced 56.27%
59,909 $1.61 Billion
Q2 2020

Jun 26, 2023
SELL
$16.25 - $26.81 $1.46 Million - $2.41 Million
-89,963 Reduced 60.03%
59,909 $1.61 Million
Q2 2020

Mar 22, 2023
BUY
$16.25 - $26.81 $42,445 - $70,027
2,612 Added 4.56%
59,909 $1.61 Million
Q2 2020

Aug 14, 2020
BUY
$16.25 - $26.81 $42,445 - $70,027
2,612 Added 4.56%
59,909 $1.61 Million
Q1 2020

Jul 12, 2023
SELL
$13.9 - $21.83 $1.29 Million - $2.02 Million
-92,575 Reduced 61.77%
57,297 $1.03 Million
Q1 2020

Mar 22, 2023
SELL
$13.9 - $21.83 $100,163 - $157,306
-7,206 Reduced 11.17%
57,297 $1.03 Million
Q1 2020

May 15, 2020
SELL
$13.9 - $21.83 $100,163 - $157,306
-7,206 Reduced 11.17%
57,297 $1.03 Million
Q4 2019

Jul 12, 2023
SELL
$14.93 - $19.53 $1.27 Million - $1.67 Million
-85,369 Reduced 56.96%
64,503 $1.14 Million
Q3 2019

Jul 12, 2023
SELL
$15.2 - $17.69 $1.3 Million - $1.51 Million
-85,369 Reduced 56.96%
64,503 $1 Million
Q3 2019

Mar 22, 2023
BUY
$15.2 - $17.69 $133,304 - $155,141
8,770 Added 15.74%
64,503 $1 Million
Q3 2019

Nov 14, 2019
BUY
$15.2 - $17.69 $133,304 - $155,141
8,770 Added 15.74%
64,503 $1 Million
Q2 2019

Jul 12, 2023
SELL
$14.75 - $17.26 $1.26 Million - $1.47 Million
-85,369 Reduced 56.96%
64,503 $1.11 Million
Q1 2019

Jul 13, 2023
SELL
$13.94 - $17.58 $1.31 Million - $1.65 Million
-94,139 Reduced 62.81%
55,733 $897,000
Q4 2018

Jul 13, 2023
SELL
$13.33 - $18.66 $1.25 Million - $1.76 Million
-94,139 Reduced 62.81%
55,733 $815,000
Q4 2018

Mar 22, 2023
SELL
$13.33 - $18.66 $423,014 - $592,156
-31,734 Reduced 36.28%
55,733 $815,000
Q4 2018

Feb 14, 2019
SELL
$13.33 - $18.66 $423,014 - $592,156
-31,734 Reduced 36.28%
55,733 $815,000
Q3 2018

Jul 13, 2023
SELL
$16.68 - $18.41 $1.57 Million - $1.73 Million
-94,139 Reduced 62.81%
55,733 $1.01 Million
Q3 2018

Mar 22, 2023
SELL
$16.68 - $18.41 $1.08 Million - $1.19 Million
-64,630 Reduced 42.49%
87,467 $1.59 Million
Q3 2018

Nov 14, 2018
BUY
$16.68 - $18.41 $529,323 - $584,222
31,734 Added 56.94%
87,467 $1.59 Million
Q4 2017

Feb 15, 2018
BUY
$16.75 - $20.8 $933,527 - $1.16 Million
55,733
55,733 $1.13 Million

Others Institutions Holding HALO

# of Institutions
543
Shares Held
125M
Call Options Held
294K
Put Options Held
180K
View Full List

About HALOZYME THERAPEUTICS, INC.

HALO Quotes by TradingView
  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email